Capricor Therapeutics Inc (CAPR) with a beta value of 4.05 appears to be a promising investment opportunity.
Capricor Therapeutics Inc (NASDAQ: CAPR) kicked off on Tuesday, down -1.39% from the previous trading day, before settling in for the closing price of $15.08.